ketoconazole has been researched along with Coccidioidomycosis in 75 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Coccidioidomycosis: Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Itraconazole shows impressive activity in this series of patients with refractory coccidioidal meningitis." | 9.06 | Itraconazole therapy for chronic coccidioidal meningitis. ( Denning, DW; Dupont, B; Stevens, DA; Tucker, RM, 1990) |
| "Ketoconazole is the newest antifungal agent evaluated for efficacy in the treatment of coccidioidomycosis and the only one used by oral administration." | 8.76 | Ketoconazole in the treatment of coccidioidomycosis. ( Galgiani, JN, 1983) |
| "Itraconazole appears efficacious and very well tolerated in patients with coccidioidomycosis." | 7.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
| "Itraconazole, a new oral triazole antifungal agent, was administered in 75 courses to patients with chronic coccidioidomycosis at dosages of 50 to 400 mg/day for a median duration of 10 months." | 7.68 | Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. ( Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM, 1990) |
| "Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 7.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
| "Fifteen patients with coccidioidal meningitis were treated with high doses of ketoconazole for up to 4 years." | 7.67 | Ketoconazole treatment of coccidioidal meningitis. ( Cloud, G; Craven, PC; Dismukes, WE; Galgiani, JN; Graybill, JR; Gregg, C; Huppert, M; Stevens, DA; Sugar, AM, 1988) |
| "The activity of two new antifungal azoles, BAY n 7133 and BAY 1 9139, against Coccidioides immitis was compared with that of ketoconazole in vitro and in experimental murine coccidioidomycosis." | 7.67 | Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. ( Hoeprich, PD; Merry, JM, 1985) |
| "Two new experimental antifungal azole drugs were compared with ketoconazole for the management of experimental murine coccidioidomycosis." | 7.67 | A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis. ( Levine, HB, 1984) |
| " We present a case of coccidioidal osteomyelitis of a tarsal bone successfully treated with local surgical debridement and oral ketoconazole and propose clinical guidelines for selecting the proper chemotherapeutic agent and for following the efficacy of the treatment regimen." | 7.67 | Coccidioidomycosis of the first cuneiform: successful treatment utilizing local debridement and long-term ketoconazole therapy. ( Buckley, SL; Burkus, JK, 1986) |
| "The effect of ketoconazole on adrenal cortical function was studied in 10 prepubertal children receiving long-term (3 to 52 months) high-dose (10 to 23 mg/kg/d) orally administered ketoconazole treatment because of systemic coccidioidomycosis." | 7.67 | Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis. ( Britton, H; Chow, D; Lightner, E; New, M; Shehab, Z, 1988) |
| "The efficacy of itraconazole, a new oral triazole, was evaluated at doses of 50-400 mg/day in 64 courses: 39 with coccidioidomycosis, and 25 with other mycoses." | 7.67 | Treatment of mycoses with itraconazole. ( Arathoon, EG; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| "Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 7.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
| "Of 29 selected patients with disseminated coccidioidomycosis, 27 were treated for at least 6 months with ketoconazole, 200 to 600 mg/d." | 7.66 | Ketoconazole for treatment of disseminated coccidioidomycosis. ( Catanzaro, A; Einstein, H; Fierer, J; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
| "Twenty-one patients with chronic pulmonary coccidioidomycosis were treated with ketoconazole." | 7.66 | Ketoconazole for treatment of chronic pulmonary coccidioidomycosis. ( Catanzaro, A; Einstein, H; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
| "Sixty patients with coccidioidomycosis were treated with ketoconazole rather than with another antifungal agent, and their responses were evaluated in relation to the predominant site of involvement." | 7.66 | Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. ( Barbee, RA; Campbell, SC; DeFelice, R; Dodge, RR; Friedman, BA; Galgiani, JN; Lincoln, LJ; Palpant, SD; Tennican, PO; Weinberg, MG, 1982) |
| "Amphotericin B was more efficacious than fluconazole." | 5.27 | Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858). ( Ahrens, J; Graybill, JR; Sun, SH, 1986) |
| "Itraconazole shows impressive activity in this series of patients with refractory coccidioidal meningitis." | 5.06 | Itraconazole therapy for chronic coccidioidal meningitis. ( Denning, DW; Dupont, B; Stevens, DA; Tucker, RM, 1990) |
| "Ketoconazole is the newest antifungal agent evaluated for efficacy in the treatment of coccidioidomycosis and the only one used by oral administration." | 4.76 | Ketoconazole in the treatment of coccidioidomycosis. ( Galgiani, JN, 1983) |
| " In 1996, a 12-year-old female chimpanzee was undergoing treatment with an experimental triazole, BayR3783, for coccidioidomycosis when she was diagnosed with severe conjunctivitis in the right eye." | 3.74 | Diagnosis and treatment of ocular coccidioidomycosis in a female captive chimpanzee (Pan troglodytes): a case study. ( Fritz, J; Hoffman, K; Murphy, J; Videan, EN, 2007) |
| "Relapse after apparently successful treatment of coccidioidomycosis has been a problem with both amphotericin B and the azoles." | 3.69 | Prediction of relapse after treatment of coccidioidomycosis. ( Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF, 1997) |
| "Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 3.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
| "The triazole SCH39304 was compared with itraconazole and fluconazole for treatment of murine coccidioidal meningitis." | 3.68 | Treatment of murine coccidioidal meningitis with SCH39304. ( Defaveri, J; Graybill, JR; Sun, SH, 1990) |
| "Itraconazole, a new oral triazole antifungal agent, was administered in 75 courses to patients with chronic coccidioidomycosis at dosages of 50 to 400 mg/day for a median duration of 10 months." | 3.68 | Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. ( Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM, 1990) |
| "Itraconazole appears efficacious and very well tolerated in patients with coccidioidomycosis." | 3.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
| "Two new experimental antifungal azole drugs were compared with ketoconazole for the management of experimental murine coccidioidomycosis." | 3.67 | A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis. ( Levine, HB, 1984) |
| "The efficacy of itraconazole, a new oral triazole, was evaluated at doses of 50-400 mg/day in 64 courses: 39 with coccidioidomycosis, and 25 with other mycoses." | 3.67 | Treatment of mycoses with itraconazole. ( Arathoon, EG; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| "Fifteen patients with coccidioidal meningitis were treated with high doses of ketoconazole for up to 4 years." | 3.67 | Ketoconazole treatment of coccidioidal meningitis. ( Cloud, G; Craven, PC; Dismukes, WE; Galgiani, JN; Graybill, JR; Gregg, C; Huppert, M; Stevens, DA; Sugar, AM, 1988) |
| "The mortality related to coccidioidal meningitis (CM) has been reduced since the introduction of amphotericin B therapy, but children with CM continue to suffer significant morbidity." | 3.67 | Imidazole therapy of coccidioidal meningitis in children. ( Britton, H; Dunn, JH; Shehab, ZM, 1988) |
| " We present a case of coccidioidal osteomyelitis of a tarsal bone successfully treated with local surgical debridement and oral ketoconazole and propose clinical guidelines for selecting the proper chemotherapeutic agent and for following the efficacy of the treatment regimen." | 3.67 | Coccidioidomycosis of the first cuneiform: successful treatment utilizing local debridement and long-term ketoconazole therapy. ( Buckley, SL; Burkus, JK, 1986) |
| "Two patients with fungal infection of the central nervous system (coccidioidal meningitis and cerebral histoplasmomas) were treated with ketoconazole for 30 months." | 3.67 | Treatment of central nervous system fungal infection with ketoconazole. ( Barnett, AM; Goodpasture, HC; Hershberger, RE; Peterie, JD, 1985) |
| " Their treatment included antifungal therapy with amphotericin B and diuresis to decrease noncardiogenic pulmonary edema." | 3.67 | Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature. ( Benowitz, BA; Jacobson, JA; Larsen, RA; Morris, AH, 1985) |
| "The activity of two new antifungal azoles, BAY n 7133 and BAY 1 9139, against Coccidioides immitis was compared with that of ketoconazole in vitro and in experimental murine coccidioidomycosis." | 3.67 | Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. ( Hoeprich, PD; Merry, JM, 1985) |
| "The effect of ketoconazole on adrenal cortical function was studied in 10 prepubertal children receiving long-term (3 to 52 months) high-dose (10 to 23 mg/kg/d) orally administered ketoconazole treatment because of systemic coccidioidomycosis." | 3.67 | Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis. ( Britton, H; Chow, D; Lightner, E; New, M; Shehab, Z, 1988) |
| "Of 29 selected patients with disseminated coccidioidomycosis, 27 were treated for at least 6 months with ketoconazole, 200 to 600 mg/d." | 3.66 | Ketoconazole for treatment of disseminated coccidioidomycosis. ( Catanzaro, A; Einstein, H; Fierer, J; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
| "Twenty-one patients with chronic pulmonary coccidioidomycosis were treated with ketoconazole." | 3.66 | Ketoconazole for treatment of chronic pulmonary coccidioidomycosis. ( Catanzaro, A; Einstein, H; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
| "We treated 29 patients with ketoconazole for systemic mycoses." | 3.66 | Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. ( Craven, PC; Donovan, W; Graybill, JR; Matthew, EB, 1982) |
| "Ketoconazole, an oral, broad-spectrum antifungal agent with relatively low toxicity, is the preferred drug for treatment of chronic mucocutaneous candidiasis and an alternative choice for treatment of thrush, vaginitis, histoplasmosis, and coccidioidomycosis." | 3.66 | Oral antifungal therapy. Current status of ketoconazole. ( Varkey, B, 1983) |
| "Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 3.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
| " We studied the ventricular and lumbar cerebrospinal fluid penetration of ketoconazole and the responses to therapy in two patients receiving ketoconazole orally, 800 mg daily, and amphotericin B intraventricularly for meningeal and extrameningeal coccidioidomycosis." | 3.66 | High-dose ketoconazole for treatment of fungal infections of the central nervous system. ( Craven, PC; Dismukes, WE; Graybill, JR; Jorgensen, JH; Levine, BE, 1983) |
| "Sixty patients with coccidioidomycosis were treated with ketoconazole rather than with another antifungal agent, and their responses were evaluated in relation to the predominant site of involvement." | 3.66 | Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. ( Barbee, RA; Campbell, SC; DeFelice, R; Dodge, RR; Friedman, BA; Galgiani, JN; Lincoln, LJ; Palpant, SD; Tennican, PO; Weinberg, MG, 1982) |
| "The therapy of coccidioidomycosis has been an early target, both experimentally and clinically, for study of new members of the azole class of drugs, because of the recognition that coccidioidomycosis is one of the most difficult mycoses to treat, and because our research group and our collaborators have been eager to pioneer new therapies for this problem pathogen." | 2.44 | Azole therapy of clinical and experimental coccidioidomycosis. ( Clemons, KV; Stevens, DA, 2007) |
| "Coccidioidomycosis is a largely self-limited fungal respiratory illness." | 2.38 | Coccidioidomycosis. ( Bronnimann, DA; Galgiani, JN, 1989) |
| "Antifungal agents useful in the treatment of coccidioidomycosis are amphotericin B, which is administered intravenously and is relatively toxic, and ketoconazole, which is administered orally and whose toxicities are less serious and reversible." | 2.37 | Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis. ( Galgiani, JN; Knoper, SR, 1988) |
| "We report a case of a colovesical fistula secondary to Coccidioides immitis infection and review the pertinent medical literature." | 2.37 | Genitourinary coccidioidomycosis. ( Evans, SG; Herman, MH; Kuntze, JR, 1988) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Mycotic pneumonias are common problems seen in small companion animals because of the wide environmental distribution of fungi and their use of airborne spores for reproduction." | 2.37 | Mycotic pneumonias. ( Roudebush, P, 1985) |
| "Coccidioidomycosis is a deep mycotic infection endemic to the southwestern United States." | 1.28 | Disseminated coccidioidomycosis with lung, skin and lymph node involvement: report of a case. ( Chen, CH; Hsu, YT; Perng, RP; Shih, JF, 1991) |
| "Amphotericin B was more efficacious than fluconazole." | 1.27 | Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858). ( Ahrens, J; Graybill, JR; Sun, SH, 1986) |
| "Two cases of pulmonary eosinophilia associated with coccidioidal infections are reported." | 1.27 | Pulmonary eosinophilia in coccidioidal infections. ( Krasne, DL; Lombard, CM; Tazelaar, HD, 1987) |
| "Of 27 patients with the acquired immunodeficiency syndrome (AIDS) in Tucson, Arizona, 7 had concurrent coccidioidomycosis." | 1.27 | Coccidioidomycosis in the acquired immunodeficiency syndrome. ( Adam, RD; Bloom, JW; Bronnimann, DA; Galgiani, JN; Habib, MP; Petersen, EA; Porter, B, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (69.33) | 18.7374 |
| 1990's | 16 (21.33) | 18.2507 |
| 2000's | 7 (9.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeiro, Rde A | 1 |
| Brilhante, RS | 1 |
| Rocha, MF | 1 |
| Medrano, DJ | 1 |
| Monteiro, AJ | 1 |
| Tavares, JL | 1 |
| de Lima, RA | 1 |
| de Camargo, ZP | 1 |
| Sidrim, JJ | 1 |
| Kamberi, P | 1 |
| Sobel, RA | 1 |
| Clemons, KV | 2 |
| Stevens, DA | 12 |
| Pappagianis, D | 3 |
| Williams, PL | 4 |
| Rubensohn, M | 1 |
| Stack, S | 1 |
| Hoffman, K | 1 |
| Videan, EN | 1 |
| Fritz, J | 1 |
| Murphy, J | 1 |
| Sheklakov, ND | 1 |
| Rukavishnikova, VM | 1 |
| Jacob, E | 1 |
| García, JJ | 1 |
| Idoria, CA | 1 |
| Fernández, M | 2 |
| Graybill, JR | 12 |
| Drutz, DJ | 1 |
| Murphy, AL | 1 |
| Davidson, W | 1 |
| Sarosi, GA | 2 |
| Catanzaro, A | 3 |
| Einstein, H | 3 |
| Levine, B | 2 |
| Ross, JB | 3 |
| Schillaci, R | 3 |
| Fierer, J | 1 |
| Friedman, PJ | 3 |
| DeFelice, R | 1 |
| Galgiani, JN | 11 |
| Campbell, SC | 1 |
| Palpant, SD | 1 |
| Friedman, BA | 1 |
| Dodge, RR | 1 |
| Weinberg, MG | 1 |
| Lincoln, LJ | 1 |
| Tennican, PO | 1 |
| Barbee, RA | 1 |
| Craven, PC | 4 |
| Donovan, W | 1 |
| Matthew, EB | 1 |
| William, PL | 1 |
| Sugar, AM | 4 |
| Pont, A | 2 |
| Azhar, S | 1 |
| Reitz, RE | 1 |
| Bochra, C | 1 |
| Smith, ER | 1 |
| Varkey, B | 1 |
| Stiller, RL | 1 |
| Kirkland, TN | 1 |
| Levine, HB | 2 |
| Jorgensen, JH | 1 |
| Dismukes, WE | 7 |
| Levine, BE | 1 |
| Stamm, AM | 1 |
| Horsburgh, CR | 1 |
| Cannady, PB | 1 |
| Kirkpatrick, CH | 1 |
| Winston, DJ | 1 |
| Kurtz, TO | 1 |
| Fleischmann, J | 1 |
| Morgan, D | 1 |
| Batzdorf, U | 1 |
| Stern, WE | 1 |
| Sturde, HC | 1 |
| Deutsch, PH | 1 |
| Quintiliani, R | 1 |
| Kuipers, S | 1 |
| Pannekoek, BJ | 1 |
| Schellekens, H | 1 |
| Oldfield, EC | 1 |
| Bone, WD | 1 |
| Martin, CR | 1 |
| Gray, GC | 1 |
| Olson, P | 1 |
| Schillaci, RF | 1 |
| Berenguer Berenguer, J | 1 |
| Dupont, B | 2 |
| Busowski, JD | 1 |
| Safdar, A | 1 |
| Briand, V | 1 |
| Lortholary, O | 1 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Ziemer, EL | 1 |
| Madigan, JE | 1 |
| Mansmann, RA | 1 |
| Hoffman, KD | 1 |
| Diaz, M | 1 |
| Puente, R | 1 |
| de Hoyos, LA | 1 |
| Cruz, S | 1 |
| Chen, CH | 1 |
| Shih, JF | 1 |
| Hsu, YT | 1 |
| Perng, RP | 1 |
| Zar, FA | 1 |
| Fish, DG | 1 |
| Ampel, NM | 1 |
| Dols, CL | 1 |
| Kelly, PC | 1 |
| Johnson, CH | 1 |
| Edwards, JE | 1 |
| Wasserman, RB | 1 |
| Clark, RJ | 1 |
| Tucker, RM | 3 |
| Denning, DW | 2 |
| Defaveri, J | 1 |
| Sun, SH | 2 |
| Cloud, GA | 3 |
| Arathoon, EG | 2 |
| Rinaldi, MG | 1 |
| Bronnimann, DA | 2 |
| Hobbs, ER | 1 |
| Britton, H | 2 |
| Shehab, Z | 1 |
| Lightner, E | 1 |
| New, M | 1 |
| Chow, D | 1 |
| Finquelievich, JL | 1 |
| Negroni, R | 1 |
| Arechavala, A | 1 |
| Ahrens, J | 1 |
| Knoper, SR | 1 |
| Dunne, WM | 1 |
| Ziebert, AP | 1 |
| Donahoe, LW | 1 |
| Standard, P | 1 |
| Gregg, C | 1 |
| Huppert, M | 1 |
| Cloud, G | 1 |
| Kauffman, CA | 1 |
| Terpenning, MS | 1 |
| Kuntze, JR | 1 |
| Herman, MH | 1 |
| Evans, SG | 1 |
| Alsip, SG | 1 |
| Shehab, ZM | 1 |
| Dunn, JH | 1 |
| Meyer, RD | 1 |
| Lombard, CM | 1 |
| Tazelaar, HD | 1 |
| Krasne, DL | 1 |
| Ingelman, JD | 1 |
| Smith, BJ | 1 |
| Rosen, T | 1 |
| Tschen, JA | 1 |
| Weisman, IM | 1 |
| Moreno, AJ | 1 |
| Parker, AL | 1 |
| Sippo, WC | 1 |
| Liles, WJ | 1 |
| Buckley, SL | 1 |
| Burkus, JK | 1 |
| Shadomy, S | 1 |
| Espinel-Ingroff, A | 1 |
| Tartaglione, TA | 1 |
| Bried, JM | 1 |
| Adam, RD | 1 |
| Habib, MP | 1 |
| Petersen, EA | 1 |
| Porter, B | 1 |
| Bloom, JW | 1 |
| Roudebush, P | 1 |
| Chen, KT | 1 |
| Schiff, JJ | 1 |
| Thorpe, CD | 1 |
| Spjut, HJ | 1 |
| Goodpasture, HC | 1 |
| Hershberger, RE | 1 |
| Barnett, AM | 1 |
| Peterie, JD | 1 |
| Larsen, RA | 1 |
| Jacobson, JA | 1 |
| Morris, AH | 1 |
| Benowitz, BA | 1 |
| Hoeprich, PD | 1 |
| Merry, JM | 1 |
17 reviews available for ketoconazole and Coccidioidomycosis
| Article | Year |
|---|---|
Azole therapy of clinical and experimental coccidioidomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Azoles; Coccidioidomycosis; Disease Models, Animal | 2007 |
[Imidazole preparations in mycology].
Topics: Animals; Antifungal Agents; Candidiasis; Clotrimazole; Coccidioidomycosis; Cryptococcosis; Dermatomy | 1984 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Ketoconazole in the treatment of coccidioidomycosis.
Topics: Administration, Oral; Adult; Aged; Coccidioidomycosis; Dose-Response Relationship, Drug; Female; Hum | 1983 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
Treatment of coccidioidomycosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chronic Dis | 1993 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
Coccidioidomycosis.
Topics: Amphotericin B; Coccidioides; Coccidioidomycosis; Humans; Immune Tolerance; Ketoconazole; Lung Disea | 1989 |
Coccidioidomycosis.
Topics: Adult; Age Factors; Amphotericin B; Arizona; Biopsy; Child; Child, Preschool; Coccidioidomycosis; De | 1989 |
Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis.
Topics: Amphotericin B; Coccidioidomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Meningitis | 1988 |
Treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Humans; Ketoconazole | 1988 |
Deep fungal infections in the elderly.
Topics: Age Factors; Aged; Amphotericin B; Blastomycosis; Coccidioidomycosis; Histoplasmosis; Humans; Ketoco | 1988 |
Genitourinary coccidioidomycosis.
Topics: Adult; Amphotericin B; Coccidioidomycosis; Genital Diseases, Male; Humans; Hydronephrosis; Intestina | 1988 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Crypt | 1985 |
4 trials available for ketoconazole and Coccidioidomycosis
| Article | Year |
|---|---|
Ketoconazole: a major innovation for treatment of fungal disease.
Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Itraconazole therapy for chronic coccidioidal meningitis.
Topics: Adolescent; Adult; Aged; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Coccidioidomycosis; | 1990 |
Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses.
Topics: Adult; Clinical Trials as Topic; Coccidioidomycosis; Dose-Response Relationship, Drug; Female; Human | 1988 |
Pharmacology and toxicity of high-dose ketoconazole.
Topics: Clinical Trials as Topic; Coccidioidomycosis; Double-Blind Method; Humans; Ketoconazole; Random Allo | 1987 |
54 other studies available for ketoconazole and Coccidioidomycosis
| Article | Year |
|---|---|
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomyco | 2009 |
A murine model of coccidioidal meningitis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Crosses, Genetic; Disease Models, Anim | 2003 |
Coccidiomycosis in a dog.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dog Diseases; Dogs; Female; Ketoconazole; Lameness, | 2003 |
Diagnosis and treatment of ocular coccidioidomycosis in a female captive chimpanzee (Pan troglodytes): a case study.
Topics: Animals; Coccidioides; Coccidioidomycosis; Conjunctivitis; Eye; Female; Ketoconazole; Models, Anatom | 2007 |
[Coccidioidomycosis. Report of a case. Review of the literature].
Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Drug Therapy, Combination; Humans; Ket | 1984 |
Disseminated blastomycosis and coccicioidomycosis in the same patient.
Topics: Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Lung D | 1981 |
Ketoconazole for treatment of disseminated coccidioidomycosis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Female; Humans; Imidazoles; Ketoconazole; Male; Middle | 1982 |
Ketoconazole for treatment of chronic pulmonary coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Female; Humans; Imidazoles; Ket | 1982 |
Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study.
Topics: Bone Diseases; Coccidioidomycosis; Dermatomycoses; Humans; Imidazoles; Ketoconazole; Lung Diseases, | 1982 |
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Adm | 1982 |
Ketoconazole effects.
Topics: Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Piperazines | 1982 |
Ketoconazole blocks testosterone synthesis.
Topics: Adult; Animals; Antifungal Agents; Coccidioidomycosis; Gynecomastia; Humans; Imidazoles; Ketoconazol | 1982 |
Oral antifungal therapy. Current status of ketoconazole.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Coccidioidomycosis; Histoplasmosis; Humans; Im | 1983 |
Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug Evaluation; | 1983 |
Treatment of coccidioidomycosis with ketoconazole: an evaluation utilizing a new scoring system.
Topics: Antifungal Agents; Bone and Bones; Bone Diseases; Coccidioidomycosis; Complement Fixation Tests; Der | 1983 |
Potential and problems with ketoconazole.
Topics: Antifungal Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Coccidioidomycosis; Endocrin | 1983 |
High-dose ketoconazole for treatment of fungal infections of the central nervous system.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Coccidioidomycosis; Drug Therapy | 1983 |
Management of fungal diseases.
Topics: Blastomycosis; Coccidioidomycosis; Complement Fixation Tests; Histoplasmosis; Humans; Imidazoles; Ke | 1983 |
Treatment of fungal infections in the bones and joints with ketoconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Bone Diseases; Child; Coccidioidomycosis; Humans; Imidazole | 1983 |
Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case report.
Topics: Adult; Amphotericin B; Arachnoiditis; Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Male; Pi | 1983 |
[Coccidioidomycosis in soldiers of the federal armed forces].
Topics: Adrenal Cortex Hormones; Adult; Amphotericin B; Coccidioidin; Coccidioidomycosis; Diagnosis, Differe | 1983 |
A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Coccidioides; Cocci | 1984 |
[Pulmonary infection with Coccidioides immitis].
Topics: Antibodies, Fungal; Antifungal Agents; Coccidioides; Coccidioidomycosis; Humans; Ketoconazole; Lung | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Prediction of relapse after treatment of coccidioidomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fl | 1997 |
Treatment for coccidioidomycosis in pregnancy?
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans | 2001 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Cocc | 2001 |
Coccidioidomycosis in horses: 15 cases (1975-1984).
Topics: Amphotericin B; Animals; Arizona; California; Coccidioidomycosis; Female; Horse Diseases; Horses; Ke | 1992 |
Itraconazole in the treatment of coccidioidomycosis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Lung Disea | 1991 |
Disseminated coccidioidomycosis with lung, skin and lymph node involvement: report of a case.
Topics: Adult; Coccidioidomycosis; Combined Modality Therapy; Dermatomycoses; Humans; Ketoconazole; Lung Dis | 1991 |
Failure of ketoconazole maintenance therapy for disseminated coccidioidomycosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Coccidioidomycosis; Fluconazole; Humans; Ketoconazole; Ma | 1991 |
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.
Topics: Adult; Amphotericin B; Arizona; California; Coccidioidomycosis; Dermatomycoses; Female; Follow-Up St | 1990 |
Treatment of murine coccidioidal meningitis with SCH39304.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, P | 1990 |
Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug | 1990 |
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Drug | 1990 |
Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Child; Coccidioidomycosis; Desoxycorticost | 1988 |
Treatment with itraconazole of experimental coccidioidomycosis in the Wistar rat.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Itraconazole; Ketoconazole; Rats; Rats, Inbred Strai | 1988 |
Treatment of mycoses with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Follow-Up Studies; Humans; Itraconazole; | 1988 |
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconaz | 1986 |
Unexpected laboratory diagnosis of latent urogenital coccidioidomycosis in a nonendemic area.
Topics: Aged; Antibodies, Fungal; Antigens, Fungal; Coccidioidomycosis; Genital Diseases, Male; Humans; Immu | 1986 |
Ketoconazole treatment of coccidioidal meningitis.
Topics: Amphotericin B; Coccidioidomycosis; Drug Therapy, Combination; Humans; Ketoconazole; Leukocyte Count | 1988 |
Imidazole therapy of coccidioidal meningitis in children.
Topics: Administration, Oral; Amphotericin B; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Coccidioi | 1988 |
Pulmonary eosinophilia in coccidioidal infections.
Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Human | 1987 |
Persistent facial plaque. Coccidioidomycosis.
Topics: Adult; Coccidioidomycosis; Humans; Ketoconazole; Male | 1987 |
Gastrointestinal dissemination of coccidioidomycosis.
Topics: Adult; Amphotericin B; Chylous Ascites; Coccidioidomycosis; Gastrointestinal Diseases; Humans; Ketoc | 1986 |
Coccidioidomycosis of the first cuneiform: successful treatment utilizing local debridement and long-term ketoconazole therapy.
Topics: Coccidioidomycosis; Debridement; Foot Diseases; Humans; Ketoconazole; Male; Middle Aged; Osteomyelit | 1986 |
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Topics: Blastomycosis; Child, Preschool; Coccidioidomycosis; Cryptococcosis; Histoplasmosis; Humans; Ketocon | 1986 |
Coccidioides immitis infections in bones and joints.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Child, Preschool; Coccidioidomycosis; Complement Fixatio | 1986 |
Coccidioidomycosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Arizona; Coccidioidomycosis; Humans; Keto | 1987 |
Coccidioidomycosis of prostate.
Topics: Aged; Coccidioidomycosis; Humans; Ketoconazole; Male; Prostatitis | 1985 |
Coccidioidal osteomyelitis in a child's finger. A case report.
Topics: Child, Preschool; Coccidioides; Coccidioidomycosis; Female; Fingers; Humans; Ketoconazole; Osteomyel | 1985 |
Treatment of central nervous system fungal infection with ketoconazole.
Topics: Aged; Coccidioidomycosis; Drug Administration Schedule; Encephalitis; Female; Histoplasmosis; Humans | 1985 |
Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature.
Topics: Adult; Amphotericin B; Antibodies, Fungal; Coccidioidomycosis; Complement Fixation Tests; Erythema; | 1985 |
Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Imidazoles; Ketoconazole; Mice; Triazo | 1985 |